Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
REXO1, RNA exonuclease 1 homolog (S. cerevisiae)-like 8, pseudogene (REXO1L8P) is a processed genomic locus annotated as a pseudogene based on high similarity to the parent REXO1 gene but contains disabling mutations that prevent functional protein expression[2][3]. Pseudogenes such as REXO1L8P typically result from duplication or retrotransposition events and serve as "molecular fossils" in the genome, evolving neutrally and lacking a clear biological role[3]. While rare cases have demonstrated potential regulatory functions for some pseudogenes, such roles remain the exception and are not supported for REXO1L8P, which is not considered a therapeutic target or biomarker[3]. If you require structured information for a bona fide therapeutic target, a functional gene or protein should be selected, as pseudogenes typically do not meet criteria for molecular targeting in drug discovery or diagnostic applications.
None.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on REXO1, RNA exonuclease 1 homolog (S. cerevisiae)-like 8, pseudogene (REXO1L8P).